Literature DB >> 7673953

Visual evoked potentials in phenylketonuria: association with brain MRI, dietary state, and IQ.

S J Jones1, G Turano, A Kriss, F Shawkat, B Kendall, A J Thompson.   

Abstract

At separate institutions, pattern reversal visual evoked potentials (VEPs) were recorded in children and older patients with phenylketonuria and compared with MRI of the brain. In nine patients aged less than 14 years, who were still on a diet low in phenylalanine, VEPs were clearly abnormal in only one and the abnormalities seen on MRI were mild. In 27 patients aged 14-31 years VEPs were abnormal in more than 80%, with significant reduction of amplitude and prolongation of latency despite the general absence of visual symptoms and abnormalities on routine neuro-ophthalmological examination. Among the older patients there was no significant correlation between VEP measures and plasma phenylalanine or tyrosine concentrations; neither was the incidence of VEP abnormalities dependent on whether or not the patients were still on a low phenylalanine diet. Some VEP amplitude measures were inversely correlated with the MRI lesion score, perhaps reflecting the severity of white matter abnormalities in the parieto-occipital region. In the older patients the amplitude of VEPs to stimulation of the central 8 degrees of the visual field was significantly correlated with IQ. The study confirms the high incidence of subclinical visual pathway involvement in older children and adults with phenylketonuria, and suggests the possibility of a link between the abnormal appearance of subcortical white matter on MRI and a physiological index of function of the CNS. As there was no evidence of general intellectual decline, it is suggested that the correlation between central field VEP amplitude and IQ may reflect abnormal development during infancy. Abnormalities on MRI, on the other hand, seem to be more closely related to current dietary state and phenylalanine concentration.

Entities:  

Mesh:

Year:  1995        PMID: 7673953      PMCID: PMC486024          DOI: 10.1136/jnnp.59.3.260

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

1.  Magnetic resonance imaging changes in early treated patients with phenylketonuria.

Authors:  A J Thompson; I Smith; B E Kendall; B D Youl; D Brenton
Journal:  Lancet       Date:  1991-05-18       Impact factor: 79.321

2.  Evidence that monoamines influence human evoked potentials.

Authors:  E W Schafer; C M McKean
Journal:  Brain Res       Date:  1975-11-28       Impact factor: 3.252

3.  Evoked potentials and electroencephalography in adolescents with phenylketonuria.

Authors:  R Korinthenberg; K Ullrich; F Füllenkemper
Journal:  Neuropediatrics       Date:  1988-11       Impact factor: 1.947

4.  Neurological deterioration in adult phenylketonuria.

Authors:  D Villasana; I J Butler; J C Williams; S M Roongta
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

5.  Intelligence and quality of dietary treatment in phenylketonuria.

Authors:  I Smith; M G Beasley; A E Ades
Journal:  Arch Dis Child       Date:  1990-05       Impact factor: 3.791

6.  Neurophysiological, psychological, and nutritional investigations during discontinuation of the phenylalanine-restricted diet in children with classic phenylketonuria.

Authors:  S M Pueschel; L Fogelson-Doyle; B Kammerer; Y Matsumiya
Journal:  J Ment Defic Res       Date:  1983-03

7.  Pattern evoked potentials in phenylketonuria.

Authors:  D Creel; B A Buehler
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1982-02

8.  Pattern-reversal visual evoked potentials in phenylketonuric children.

Authors:  A Landi; A Ducati; R Villani; R Longhi; E Riva; C Rodocanachi; M Giovannini
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

9.  Pattern reversal visual evoked potentials in phenylketonuria.

Authors:  M Giovannini; R Valsasina; R Villani; A Ducati; E Riva; A Landi; R Longhi
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

10.  Neurological deterioration in young adults with phenylketonuria.

Authors:  A J Thompson; I Smith; D Brenton; B D Youl; G Rylance; D C Davidson; B Kendall; A J Lees
Journal:  Lancet       Date:  1990-09-08       Impact factor: 79.321

View more
  8 in total

1.  Long term decline of P100 amplitude in migraine with aura.

Authors:  N M Khalil; N J Legg; D J Anderson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-10       Impact factor: 10.154

2.  Diffusion-weighted imaging of white matter abnormalities in patients with phenylketonuria.

Authors:  M D Phillips; P McGraw; M J Lowe; V P Mathews; B E Hainline
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

3.  Altered visual functions, macular ganglion cell and papillary retinal nerve fiber layer thickness in early-treated adult PKU patients.

Authors:  Csilla Serfozo; Andras Gellert Barta; Endre Horvath; Csaba Sumanszki; Bela Csakany; Miklos Resch; Zoltan Zsolt Nagy; Peter Reismann
Journal:  Mol Genet Metab Rep       Date:  2020-09-22

4.  Subclinical visual impairment in phenylketonuria. A neurophysiological study (VEP-P) with clinical, biochemical, and neuroradiological (MRI) correlations.

Authors:  V Leuzzi; S Rinalduzzi; F Chiarotti; P Garzia; G Trasimeni; N Accornero
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

5.  Estimating the probability of IQ impairment from blood phenylalanine for phenylketonuria patients: a hierarchical meta-analysis.

Authors:  Christopher J Fonnesbeck; Melissa L McPheeters; Shanthi Krishnaswami; Mary Louise Lindegren; Tyler Reimschisel
Journal:  J Inherit Metab Dis       Date:  2012-11-30       Impact factor: 4.982

6.  Reduced macular thickness and macular vessel density in early-treated adult patients with PKU.

Authors:  Csilla Serfozo; Andras Gellert Barta; Endre Horvath; Csaba Sumanszki; Bela Csakany; Miklos Resch; Zoltan Zsolt Nagy; Peter Reismann
Journal:  Mol Genet Metab Rep       Date:  2021-05-05

7.  Deletion and duplication of 16p11.2 are associated with opposing effects on visual evoked potential amplitude.

Authors:  Jocelyn J LeBlanc; Charles A Nelson
Journal:  Mol Autism       Date:  2016-06-27       Impact factor: 7.509

8.  Effect of Delayed Diagnosis of Phenylketonuria With Imaging Findings of Bilateral Diffuse Symmetric White Matter Lesions: A Case Report and Literature Review.

Authors:  Shuna Chen; Mingqin Zhu; Yulei Hao; Jiachun Feng; Ying Zhang
Journal:  Front Neurol       Date:  2019-10-04       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.